Clinicopathological Analysis of Ultrasound-guided Vacuum-assisted Breast Biopsy for the Diagnosis and Treatment of Breast Disease

Park, Hai Lin; Kim, Ka Young; Park, Jong Seob; Shin, Jumi A.; Kim, Hye-Rin; Yang, Bora; Kim, Jiyoung; Shim, Jae‐Yong; Shin, Eunah; Noh, Songmi

doi:10.21873/anticanres.12499

Cited by 18 publications

(20 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…VABB is also preferred for biopsy of lesions adjacent to the chest wall or a prosthesis. [ 5 , 10 ] For lesions with inconsistent results by imaging evaluation and CNB, VABB can be performed again to enhance the diagnostic accuracy. [ 2 ] For VABB used for diagnosis, the expert group recommends that a clip can be placed simultaneously to enhance the accuracy of lesion resection in subsequent open surgery, reduce the rate of secondary resection of the incision margins in breast-conserving surgery, and reduce recurrence.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Hao

Bai

et al. 2021

Chinese Medical Journal

View full text Add to dashboard Cite

Ultrasound-guided vacuum-assisted breast biopsy (VABB) is a common technique in breast surgery. To standardize this technique, the Chinese Society of Breast Surgery (CSBrS) re-evaluated the quality of evidence for clinical studies of VABB, referring to the grading of recommendations assessment, development, and evaluation, and developed the Clinical Practice Guidelines for Ultrasoundguided vacuum-assisted breast biopsy: CSBrS Practice Guidelines 2021, in accordance with the Expert Consensus and Operation Guidelines for Ultrasound-guided Vacuumassisted Breast Biopsy Surgery (2017) combined with data from clinical practice in breast surgery in China, providing a reference for breast surgeons in China.

show abstract

Section: Discussionmentioning

confidence: 99%

“…For BI-RADS classification III lesions measuring ≤2.0 cm, the complete resection rate of VABB is nearly 100%, while for lesions measuring >2.0 cm, the probability of residual lesions is positively correlated with the tumor size. [ 2 , 5 , 8 , 12 ]…”

Section: Discussionmentioning

confidence: 99%

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Hao

Bai

et al. 2021

Chinese Medical Journal

View full text Add to dashboard Cite

show abstract

“…Two studies included benign phyllodes tumors [31,32]. The indications of 16 studies vary from BI-RADS 1-4b [11,[16][17][18][19][20][22][23][24]28,[30][31][32][33][34]37]. Perez-Fuentes et al include eight patients with BI-RADS 5 [13] Hahn et al included two patients with BI-RADS 5 [23] Jiang et al included 48 patients with BI-RADS 5 in cases where patients desired biopsy [30].…”

Section: Selection and Characteristicsmentioning

confidence: 99%

Efficacy and Safety of Vacuum-Assisted Excision for Benign Breast Mass Lesion: A Meta-Analysis

et al. 2021

View full text Add to dashboard Cite

Background and Objective: Breast mass lesions are common; however, determining the malignant potential of the lesion can be ambiguous. Recently, to evaluate breast mass lesions, vacuum-assisted excision (VAE) biopsy has been widely used for both diagnostic and therapeutic purposes. This study aimed to investigate the therapeutic role of VAE. Materials and Methods: Relevant articles were obtained by searching PubMed and EMBASE on 3 September 2021. Meta-analyses were performed using odds ratios and proportions. To assess heterogeneity, we conducted a subgroup analysis and meta-regression tests. Results: Finally, 26 studies comprising 18,170 patients were included. All of these were observational studies. The meta-analysis showed that the complete resection rate of VAE was 0.930. In the meta-regression test, there was no significant difference. The meta-analysis showed a recurrence rate of 0.039 in the VAE group. The meta-regression test showed no statistical significance. Postoperative hematoma, pain, and ecchymosis after VAE were 0.092, 0.082, and 0.075, respectively. Conclusion: VAE for benign breast lesions showed favorable outcomes with respect to complete resection and complications. This meta-analysis suggested that VAE for low-risk benign breast lesions is a reasonable option for both diagnostic and therapeutic purposes.

show abstract

“…Currently, US-VAEB tends to be regarded as the best diagnostic way to differentiate benign from malignant breast changes seen at imaging and is popular in China [ 11 , 12 ]. VAEB could replace core needle biopsy and open surgical biopsy for diagnoses of breast diseases and treatment of benign breast lesions [ 13 , 14 ]. It has several advantages, including the ability to get more samples for a more reliable histological diagnosis, the ability to complete removal of the breast lesion, and performance under the real-time guidance of ultrasound [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

Breast lesions excised via vacuum-assisted system: could we get any clues for B3 lesions before excision biopsy?

Zheng

Xing

et al. 2021

BMC Cancer

View full text Add to dashboard Cite

Background The purpose of this study was to determine the validity of the ultrasound features as well as patient characteristics assigned to B3 (uncertain malignant potential) breast lesions before vacuum-assisted excision biopsy (VAEB). Methods This study population consisted of 2245 women with breast-nodular abnormalities, which were conducted ultrasound-guided VAEB (US-VAEB). Patient’s clinical and anamnestic data and lesion-related ultrasonic feature variables of B3 captured before US-VAEB were compared with those of benign or malignant cases, using histopathological results as a benchmark. Results The proportions of benign, B3 and malignant breast lesions diagnosed post-US-VAEB were 88.5, 8.2 and 3.4% respectively. B3 high frequent occurred in BI-RADS-US grade 3 (7.7%), grade 4a (11.0%) and grade 4b (9.1%). The overall malignancy underestimation rate of B3 was 4.4% (8/183). Malignant lesions were found mostly in the range of BI-RADS grade 4b (27.3%), grade 4c (33.3%) and grade 5 (100%). Multivariate binary logistic regression analyses (B3 vs benign) showed that non-menopausal patients (95% CI 1.628–8.616, P = 0.002), single (95% CI 1.370–2.650, P = 0.000) or vascularity (95% CI 1.745–4.150, P = 0.000) nodules in ultrasonic features were significant risk factors for B3 occurrences. In addition, patients elder than 50 years (95% CI 3.178–19.816, P = 0.000), unclear margin (95% CI 3.571–14.119, P = 0.000) or suspicious calcification (95% CI 4.010–30.733, P = 0.000) lesions were significantly associated with higher risks of malignant potentials for B3 cases (malignant vs B3). Conclusion The results of this study indicate that ultrasound findings and patients’ characteristics might provide valuable information for distinguishing B3 lesions from benign breast abnormalities before VAEB, and help to reduce malignancy underestimation of B3.

show abstract

Clinicopathological Analysis of Ultrasound-guided Vacuum-assisted Breast Biopsy for the Diagnosis and Treatment of Breast Disease

Abstract: VABB could replace ultrasound-guided core biopsy and surgical excisional biopsy for the diagnosis of breast disease and the treatment of benign breast lesions.

Cited by 18 publications

References 21 publications

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Efficacy and Safety of Vacuum-Assisted Excision for Benign Breast Mass Lesion: A Meta-Analysis

Breast lesions excised via vacuum-assisted system: could we get any clues for B3 lesions before excision biopsy?

Contact Info

Product

Resources

About